Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
UNKNOWN
NCT03633604

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Sponsor: Michael Boisen

View on ClinicalTrials.gov

Summary

HBOC-201 provides an oxygen treatment bridge and can be used to eliminate, delay, or reduce the need for red blood cell transfusions in anemic patients This is an expanded access IND protocol, and will provide treatment with HBOC-201 to severely anemic adults for whom blood is not an option

Official title: An Expanded IND Access Investigation of HBOC-201 Infusion in Patients With Severe Acute Anemia Who Are Unable to Receive Red Blood Cell Transfusion

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

EXPANDED_ACCESS

Enrollment

Not specified

Start Date

Not specified

Completion Date

Not specified

Last Updated

2026-07-20

Healthy Volunteers

Not specified

Conditions

Interventions

BIOLOGICAL

HBOC-201

Intravenous administration of a hemoglobin based oxygen carrier (HBOC) in patients with life-threatening anemia, for whom allogeneic blood transfusion is not an option.

Locations (1)

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States